Townsquare Capital LLC Acelrx Pharmaceuticals Inc Transaction History

Townsquare Capital LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.03 - $1.7 $54,153 - $89,379	-52,576 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$1.18 - $1.98 $8,850 - $14,850	-7,500 Reduced 12.48%	52,576 $65,000
Q3 2020 Dec 01, 2020	BUY	$1.01 - $1.81 $60,676 - $108,737	60,076 New	60,076 $80,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Townsquare Capital LLC with notifications on news.